JOEL MCCLOUD: Open Payments
NPI 1801836457 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 75 payments from 23 companies in 2025. Trend: 2023 $2,994 · 2024 $3,951 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $328 |
| PFIZER INC. | 14 | $270 |
| Alnylam Pharmaceuticals Inc. | 8 | $238 |
| AstraZeneca Pharmaceuticals LP | 7 | $202 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| Abbott Laboratories | 5 | $85 |
| ViiV Healthcare Company | 1 | $72 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
Products named: AMVUTTRA, Ozempic, WAINUA, Kerendia, ELIQUIS, FREESTYLE LIBRE 3, VYNDAQEL, PREVNAR 20.
Industry payments across AL — which companies pay providers there.
